Inventor
CHANG YONG MIN
KR13 patents
⚠️ This page may combine multiple inventors who share the name “CHANG YONG MIN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
KYUNGPOOK NAT UNIV IND ACADEMIC COOP FOUND
6 patentsUS12370271B2Jul 29, 2025
Gadolinium-based compound, preparation method therefor, and MRI contrast agent containing same
KYUNGPOOK NAT UNIV IND ACADEMIC COOP FOUND0 citations56
US12589169B2Mar 31, 2026
Compound and MRI contrast agent containing same
KYUNGPOOK NAT UNIV IND ACADEMIC COOP FOUND0 citations51
US12576167B2Mar 17, 2026
Gadolinium-based compound, method for producing same, and MRI contrast agent containing same
KYUNGPOOK NAT UNIV IND ACADEMIC COOP FOUND0 citations51
US12466843B2Nov 11, 2025
Gadolinium-based compound, method for producing same, and MRI contrast agent containing same
KYUNGPOOK NAT UNIV IND ACADEMIC COOP FOUND0 citations51
US10759817B2Sep 1, 2020
Gadolinium complex, method for synthesis of the gadolinium complex, and MRI contrast agent including the gadolinium complex
KYUNGPOOK NAT UNIV IND ACADEMIC COOP FOUND0 citations49
US10245328B2Apr 2, 2019
Gadolinium complex comprising DO3A-tranexamic acid conjugate
KYUNGPOOK NAT UNIV IND ACADEMIC COOP FOUND0 citations49
ETNOVA THERAPEUTICS CORP
3 patentsUS12098147B2Sep 24, 2024
Compound having novel structure, complex comprising same, anti-cancer pharmaceutical composition, and anti-cancer drug
ETNOVA THERAPEUTICS CORP2 citations62
US12551468B2Feb 17, 2026
Pharmaceutical composition for oral administration, for treatment of liver cancer
ETNOVA THERAPEUTICS CORP0 citations52
US12404255B2Sep 2, 2025
Compound and pharmaceutical composition containing same for treating or preventing neural damage, neural disease, or developmental disorder through promoting proliferation, differentiation, and/or regeneration of neural cells
ETNOVA THERAPEUTICS CORP0 citations43